PubRank

Anna Mondino

Author PubWeight™ 39.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood 2012 3.02
2 Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 2004 2.75
3 Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J Immunol 2006 1.81
4 IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. Blood 2008 1.55
5 IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes. Blood 2013 1.48
6 Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy. J Immunol 2012 1.17
7 Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Mol Cell Biol 2005 1.17
8 Autonomic denervation of lymphoid organs leads to epigenetic immune atrophy in a mouse model of Krabbe disease. J Neurosci 2007 1.17
9 The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci 2004 1.14
10 Reduced functional avidity promotes central and effector memory CD4 T cell responses to tumor-associated antigens. J Immunol 2010 1.12
11 Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development. J Exp Med 2008 1.08
12 Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 2008 1.06
13 The tuberous sclerosis complex: balancing proliferation and survival. Biochem Soc Trans 2011 1.01
14 Clonal anergy is maintained independently of T cell proliferation. J Immunol 2002 1.00
15 Reticulocyte parameters: markers of early response to oral treatment in children with severe iron-deficiency anemia. J Pediatr Hematol Oncol 2012 0.96
16 Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes. Cancer Res 2003 0.95
17 Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses. Oncoimmunology 2013 0.93
18 Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings. Cancer Res 2013 0.93
19 Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer. Trends Immunol 2008 0.93
20 A signaling loop of REST, TSC2 and β-catenin governs proliferation and function of PC12 neural cells. J Cell Sci 2011 0.90
21 Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantation. Cancer Res 2013 0.87
22 Cytosolic sequestration of Prep1 influences early stages of T cell development. PLoS One 2008 0.86
23 Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk. J Immunol 2005 0.85
24 Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation. Eur J Immunol 2011 0.85
25 IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cells. Eur J Immunol 2010 0.84
26 Concurrent allorecognition has a limited impact on posttransplant vaccination. J Immunol 2011 0.82
27 Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy. Eur J Immunol 2002 0.81
28 TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity. Mol Immunol 2010 0.81
29 Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors. Cancer Res 2010 0.79
30 Tumor-targeting vaccination instructs graft-vs.-tumor immune responses. Oncoimmunology 2013 0.79
31 Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses. Cancer Res 2008 0.78
32 Immune surveillance and anti-tumor immune responses: an anatomical perspective. Immunol Lett 2005 0.76
33 Antigen-experienced CD4(+) T cells limit naïve T-cell priming in response to therapeutic vaccination in vivo. Cancer Res 2010 0.76
34 Transplant Site Influences the Immune Response After Islet Transplantation: Bone Marrow Versus Liver. Transplantation 2017 0.76
35 Trick to treat: tricking the thymus to treat cancer. Blood 2013 0.75
36 Absence of Rac1 and Rac3 GTPases in the nervous system hinders thymic, splenic and immune-competence development. Eur J Immunol 2011 0.75
37 The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administration. J Immunol 2005 0.75
38 Tumors hamper the immunogenic competence of CD4+ T cell-directed dendritic cell vaccination. J Immunol 2007 0.75